Literature DB >> 2380098

Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.

B T Hill1, S A Shellard, L K Hosking, A M Fichtinger-Schepman, P Bedford.   

Abstract

In vitro exposure of a human testicular teratoma continuous cell line to fractionated X-irradiation resulted in the expression of resistance to cisplatin. In two independently-derived sublines, designated SUSA-DXR13 and SUSA-DXR10 resulting from treatment with either 13 fractions of 1.5 Gy (dose required to reduce survival by 1 log) or 10 fractions of 3 Gy (dose required to reduce survival by 2 logs) respectively, the IC50 values for cisplatin were 2- and 3.1-fold higher than that of the parental cell line. These sublines were cross-resistant to carboplatin (approximately 2-fold) but not to adriamycin and they showed unaltered radiosensitivities. The SUSA-DXR10 subline expressed some cross-resistance to mitomycin C and melphalan but none to Carmustine (BCNU). Total glutathione content was significantly reduced in both SUSA-DXR10 and SUSA-DXR13 cells, but the activities of associated enzymes, including the glutathione S-transferases, peroxidase and reductase were not modified significantly in the resistant sublines. Resistance in the SUSA-DXR10 subline was associated with significantly decreased 195mcisplatin uptake (p less than 0.01), but this was not reflected in a reduced level of drug bound to the DNA. The formation and removal of four platinum-DNA adducts were immunochemically quantitated. Immediately following drug treatment there was a higher level of total platination of the DNA in the resistant subline indicative of increased tolerance to DNA damage. After an 18 hr post treatment incubation, there was an indication of some repair capacity in this SUSA-DXR10 cell line, which was not apparent in the parental cells. Neither the parental nor the SUSA-DXR10 cell line was proficient in the repair of the major adduct Pt-GG, whereas both lines repaired the monofunctional adduct and the adduct Pt(GMP)2. SUSA-DXR10 cells were also able to repair the intrastrand adduct Pt-AG and interstrand crosslinks, unlike the repair deficient parental cells. Higher levels of interstrand crosslinks were characteristic of the SUSA-DXR10 subline. These observations therefore implicate both enhanced repair and increased tolerance of DNA damage as mechanisms of resistance to cisplatin resulting from in vitro exposure of a human teratoma cell line to fractionated X-irradiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380098     DOI: 10.1016/0360-3016(90)90137-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

Review 1.  Pharmacological methods to transcriptionally modulate double-strand break DNA repair.

Authors:  Alanna R Kaplan; Peter M Glazer
Journal:  Int Rev Cell Mol Biol       Date:  2019-12-18       Impact factor: 6.813

2.  Radiation- and chemoinduced multidrug resistance in colon carcinoma cells.

Authors:  Detlef Bartkowiak; Michael Stempfhuber; Thomas Wiegel; Dirk Bottke
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

3.  Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemia.

Authors:  Kazutaka Takagi; Yasukazu Kawai; Takahiro Yamauchi; Hiromichi Iwasaki; Takanori Ueda
Journal:  Int J Hematol       Date:  2011-09-23       Impact factor: 2.490

4.  Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD.

Authors:  Munetaka Ozeki; Daniel Tamae; De-Xing Hou; Tieli Wang; Thomas Lebon; Douglas R Spitz; Jian Jian Li
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

5.  Treatment of DNA with ammonium bicarbonate or thiourea can lead to underestimation of platinum-DNA monoadducts.

Authors:  G R Gibbons; J D Page; S G Chaney
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.

Authors:  D E Szymkowski; K Yarema; J M Essigmann; S J Lippard; R D Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patients.

Authors:  S Ghazal-Aswad; L Hogarth; A G Hall; M George; D P Sinha; M Lind; A H Calvert; J P Sunter; D R Newell
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

8.  Radiation-induced transient cisplatin resistance in murine fibrosarcoma cells associated with elevated metallothionein content.

Authors:  H Eichholtz-Wirth; G Reidel; B Hietel
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo.

Authors:  H Eichholtz-Wirth; B Hietel
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

10.  Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.

Authors:  H J Groen; S Sleijfer; C Meijer; H H Kampinga; A W Konings; E G De Vries; N H Mulder
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.